Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
about
The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.Homing in: Mechanisms of Substrate Targeting by Protein Kinases.Lung Cancer: EGFR Inhibitors with Low Nanomolar Activity against a Therapy-Resistant L858R/T790M/C797S Mutant.Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
P2860
Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cancer-Associated Mutations in ...... ity and Substrate Recognition.
@ast
Cancer-Associated Mutations in ...... ity and Substrate Recognition.
@en
type
label
Cancer-Associated Mutations in ...... ity and Substrate Recognition.
@ast
Cancer-Associated Mutations in ...... ity and Substrate Recognition.
@en
prefLabel
Cancer-Associated Mutations in ...... ity and Substrate Recognition.
@ast
Cancer-Associated Mutations in ...... ity and Substrate Recognition.
@en
P2860
P1433
P1476
Cancer-Associated Mutations in ...... ity and Substrate Recognition.
@en
P2093
Tiffany Tsui
W Todd Miller
P2860
P304
P356
10.1021/ACS.BIOCHEM.5B00303
P407
P577
2015-05-13T00:00:00Z